These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

977 related items for PubMed ID: 16949266

  • 1. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D.
    Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
    [Abstract] [Full Text] [Related]

  • 2. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST, Djukanović R, Casale T, Bousquet J.
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [Abstract] [Full Text] [Related]

  • 3. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):302-7. PubMed ID: 16464445
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
    Vignola AM, Humbert M, Bousquet J, Boulet LP, Hedgecock S, Blogg M, Fox H, Surrey K.
    Allergy; 2004 Jul 08; 59(7):709-17. PubMed ID: 15180757
    [Abstract] [Full Text] [Related]

  • 5. Omalizumab in the treatment of severe asthma: efficacy and current problems.
    Pelaia G, Renda T, Romeo P, Busceti MT, Maselli R.
    Ther Adv Respir Dis; 2008 Dec 08; 2(6):409-21. PubMed ID: 19124386
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
    Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C.
    J Allergy Clin Immunol; 2005 Mar 08; 115(3):459-65. PubMed ID: 15753888
    [Abstract] [Full Text] [Related]

  • 8. Omalizumab: efficacy in allergic disease.
    Spector S.
    Panminerva Med; 2004 Jun 08; 46(2):141-8. PubMed ID: 15507883
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A, Sternon J.
    J Pharm Belg; 2006 Jun 08; 61(3):83-7. PubMed ID: 17058881
    [Abstract] [Full Text] [Related]

  • 11. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
    Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, van As A, Gupta N.
    J Allergy Clin Immunol; 2001 Aug 08; 108(2):184-90. PubMed ID: 11496232
    [Abstract] [Full Text] [Related]

  • 12. Anti-IgE in severe persistent allergic asthma.
    Fox H.
    Respirology; 2007 Nov 08; 12 Suppl 3():S22-8; discussion S45-7. PubMed ID: 17956516
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE.
    Pharmacol Ther; 2007 Jan 08; 113(1):121-33. PubMed ID: 17000005
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibody.
    D'Amato G.
    Expert Opin Biol Ther; 2003 Apr 08; 3(2):371-6. PubMed ID: 12662149
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
    Niven R, Chung KF, Panahloo Z, Blogg M, Ayre G.
    Respir Med; 2008 Oct 08; 102(10):1371-8. PubMed ID: 18657960
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treating moderate-to-severe allergic asthma with anti-IgE monoclonal antibody (omalizumab). An update.
    D'Amato G, Perticone M, Bucchioni E, Salzillo A, D'Amato M, Liccardi G.
    Eur Ann Allergy Clin Immunol; 2010 Aug 08; 42(4):135-40. PubMed ID: 21114196
    [Abstract] [Full Text] [Related]

  • 20. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma.
    Bousquet J, Cabrera P, Berkman N, Buhl R, Holgate S, Wenzel S, Fox H, Hedgecock S, Blogg M, Cioppa GD.
    Allergy; 2005 Mar 08; 60(3):302-8. PubMed ID: 15679714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.